Mexico City, December 1, 2017— Representatives from Mexico, Canada, and the United States met in Mexico City December 1, 2017, for the Second Meeting of the North American Drug Dialogue (NADD).
As part of the commitments of the North American Leaders Summit (NALS), the President of Mexico, the President of the United States and the Prime Minister of Canada agreed to annually convene the North American Drug Dialogue to promote greater trilateral coordination.
Delegates from the three countries reviewed the progress made since the last meeting in October 2016 on opioid policies and actions impacting the continent. The delegations also discussed the increase in synthetic drugs; the diversion of chemical precursors from licit to illicit use; and current activities to reduce the demand for drugs.
In the framework of the Second Meeting of the Dialogue, the three countries reaffirmed their commitment to achieve effective solutions to the challenge posed by the production, trafficking, and consumption of drugs in North America.